APA

Watson N. S., Adams C., Belton D., Brown D., Burns-Kurtis C. L., Chaudry L., Chan C., Convery M. A., Davies D. E., Exall A. M., Harling J. D., Irvine S., Irving W. R., Kleanthous S., McLay I. M., Pateman A. J., Patikis A. N., Roethke T. J., Senger S., Stelman G. J., Toomey J. R., West R. I., Whittaker C., Zhou P. & Young R. J. (20110705). The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. : Bioorganic & medicinal chemistry letters.

Chicago

Watson Nigel S, Adams Carl, Belton David, Brown David, Burns-Kurtis Cynthia L, Chaudry Laiq, Chan Chuen, Convery Máire A, Davies David E, Exall Anne M, Harling John D, Irvine Stephanie, Irving Wendy R, Kleanthous Savvas, McLay Iain M, Pateman Anthony J, Patikis Angela N, Roethke Theresa J, Senger Stefan, Stelman Gary J, Toomey John R, West Robert I, Whittaker Caroline, Zhou Ping and Young Robert J. 20110705. The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. : Bioorganic & medicinal chemistry letters.

Harvard

Watson N. S., Adams C., Belton D., Brown D., Burns-Kurtis C. L., Chaudry L., Chan C., Convery M. A., Davies D. E., Exall A. M., Harling J. D., Irvine S., Irving W. R., Kleanthous S., McLay I. M., Pateman A. J., Patikis A. N., Roethke T. J., Senger S., Stelman G. J., Toomey J. R., West R. I., Whittaker C., Zhou P. and Young R. J. (20110705). The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. : Bioorganic & medicinal chemistry letters.

MLA

Watson Nigel S, Adams Carl, Belton David, Brown David, Burns-Kurtis Cynthia L, Chaudry Laiq, Chan Chuen, Convery Máire A, Davies David E, Exall Anne M, Harling John D, Irvine Stephanie, Irving Wendy R, Kleanthous Savvas, McLay Iain M, Pateman Anthony J, Patikis Angela N, Roethke Theresa J, Senger Stefan, Stelman Gary J, Toomey John R, West Robert I, Whittaker Caroline, Zhou Ping and Young Robert J. The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs. : Bioorganic & medicinal chemistry letters. 20110705.